Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Integra Lifesciences (NQ: IART )

17.41 -0.06 (-0.34%)
Streaming Delayed Price Updated: 12:56 PM EDT, Sep 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 384,539
Open 17.25
Bid (Size) 17.40 (3)
Ask (Size) 17.42 (4)
Prev. Close 17.47
Today's Range 17.14 - 17.43
52wk Range 16.96 - 45.42
Shares Outstanding 84,579,542
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Kaskela Law LLC Announces Shareholder Investigation of Integra LifeSciences Holdings Corp. (NASDAQ: IART) and Encourages Long-Term IART Shareholders to Contact the Firm
From KASKELA LAW LLC
Via Business Wire
Expert Outlook: Integra Lifesciences Through The Eyes Of 8 Analysts
Via Benzinga

Performance

YTD
-59.75%
-59.75%
1 Month
-16.50%
-16.50%
3 Month
-39.72%
-39.72%
6 Month
-49.43%
-49.43%
1 Year
-55.27%
-55.27%

More News

Read More
Wall Street's Top 10 Stock Calls This Week - Saturday, Aug. 3
Via Talk Markets
Integra LifeSciences Analysts Cut Their Forecasts After Q2 Results
Via Benzinga
Why Bank of Marin Bancorp Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
NASDAQ:IART is an undervalued gem with solid fundamentals.
Via Chartmill
Why Integra Lifesciences Stock Is Sinking Today
Via The Motley Fool
Topics Earnings
Exposures Financial
IART Stock Earnings: Integra Lifesciences Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Abbott, Integra LifeSciences And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
The 3 Best Brain-Computer Interface Stocks to Buy Now
Via InvestorPlace
INTEGRA LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Integra LifeSciences Holdings Corporation - IART
From Kahn Swick & Foti, LLC
Via Business Wire
8 Analysts Have This To Say About Integra Lifesciences
Via Benzinga
A Glimpse Into The Expert Outlook On Integra Lifesciences Through 8 Analysts
Via Benzinga
For those who appreciate value investing, NASDAQ:IART is a compelling option with its solid fundamentals.
Via Chartmill
INTEGRA LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Integra LifeSciences Holdings Corporation - IART
From Kahn Swick & Foti, LLC
Via Business Wire
NASDAQ:IART appears to be flying under the radar despite its strong fundamentals.
Via Chartmill
CrowdStrike, KKR, GoDaddy To Join S&P 500 In Quarterly Rebalance; Stocks Jump
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
$1.5M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying
Via Benzinga
NASDAQ:IART is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.
Via Chartmill
Stocks On Track For Third Green Session, Palantir Ignites Rally In Chipmakers, Commodities Rebound: What's Driving Markets Monday?
Via Benzinga
Spirit Airlines Posts Weak Results, Joins Integra LifeSciences, Bowlero And Other Big Stocks Moving Lower On Monday
Via Benzinga
Why Perficient Shares Are Trading Higher By Around 53%? Here Are 20 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why Is Medical Device Maker Integra LifeSciences Stock Falling On Monday?
Via Benzinga
IART Stock Earnings: Integra Lifesciences Meets EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.